Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.

Publication Year: 2022

DOI:
10.1159/000522389

PMCID:
PMC9294968

PMID:
35978601

Journal Information

Full Title: Liver Cancer

Abbreviation: Liver Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest Statement H. Aikata received honoraria from Eisai and Bayer. S. Ogasawara received grant support, advisory fees, and honoraria from Bayer and Eisai. K. Chayama has received honoraria from AbbVie, MSD, Gilead Sciences Inc., Bristol Myers Squibb (BMS), Sumitomo Dainippon Pharma, Otsuka, and Tanabe Mitsubishi and grants and research funding from Sumitomo Dainippon Pharma. N. Kato received grant support, advisory fees, and honoraria from Bayer and Eisai. The authors declare no conflicts of interest."

Evidence found in paper:

"Funding Sources No financial support was received for this study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025